North America Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

The North America infant, child, and maternal probiotic supplements market is expected to grow from US$ 237.56 million in 2022 to US$ 386.82 million by 2028; it is estimated to grow at a CAGR of 8.5% from 2022 to 2028.

Due to the benefits of infant and child probiotic supplements, it has also gained immense traction among parents. Probiotics help relieve acute constipation, acid reflux, and colic in healthy infants and children. Moreover, probiotics help build a strong barrier against distress, causing bacteria in the gastrointestinal (GI) tract of infants and children, improving their immunity and digestive health. Probiotic supplements also help in preventing children from eczema and other allergies. Parents are increasingly seeking supplements infused with probiotics to support a range of health requirements for their children. According to a survey conducted by Fonterra Co-operative Group Limited and Euromonitor, 52% of the surveyed population stated that digestive health is the primary reason for giving probiotic vitamins and supplements to their children, while 41% voted for general health and 38% voted for immune health. Thus, the rising importance of specific nutrition for children's proper development and well-being and the increasing demand for probiotic supplements in pediatric nutrition are the key factors driving the infant, child, and maternal probiotic supplements market growth.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America infant, child, and maternal probiotic supplements market growth at a notable CAGR during the forecast period.

North America Infant, Child, and Maternal Probiotic Supplements Market Segmentation

The market for North America infant, child, and maternal probiotic supplements market is segmented into form, end user, and country. Based on form, the market is categorized into capsules and soft gels, gummies, liquid, and others. Based on end user, the market is segmented into infant and toddler, children, and maternal women. Based on country, the North America infant, child, and maternal probiotic supplements market is segmented into the US, Canada, and Mexico.

North America Infant, Child, and Maternal Probiotic Supplements Market - Companies Mentioned

Bayer Corporation; MaryRuth Organics, LLC; Mommy’s Bliss Inc.; Pharmavite LLC; Nestlé S.A.; BioGaia AB; Evolve Biosystems; Lovebug Probiotics; Biomeology; and Nordic Naturals are a few major companies operating in the North America infant, child, and maternal probiotic supplements market.

1. Introduction

1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation

2. Key Takeaways

3. Research Methodology

3.1 Scope of the Study
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis Formulation:
3.2.4 Macro-economic Factor Analysis:
3.2.5 Developing Base Number:
3.2.6 Data Triangulation:
3.2.7 Country Level Data:
3.2.8 Limitations and Assumptions:

4. North America Infant, Child, and Maternal Probiotic Supplements Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes
4.3 Expert Opinion
4.4 Ecosystem Analysis

5. North America Infant, Child, and Maternal Probiotic Supplements Market - Key Market Dynamics

5.1 Market Drivers
5.1.1 Rising Demand for Probiotic Supplements in Paediatric Nutrition
5.1.2 Growing Awareness Regarding Benefits of Probiotic Supplements among Pregnant Women
5.2 Market Restraints
5.2.1 Consumer Perceptions on Probiotic Supplements for Newburn
5.3 Market Opportunities
5.3.1 Surging Demand in Developing Regions
5.4 Future Trends
5.4.1 Increasing Research and Development in Infant and Maternal Probiotics Space
5.5 Impact Analysis of Drivers and Restraints

6. Infant, Child, and Maternal Probiotic Supplements - Market Analysis

6.1 North America Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)

7. North America Infant, Child, And Maternal Probiotic Supplements Market Analysis - By Form

7.1 Overview
7.2 North America Infant, Child, And Maternal Probiotic Supplements Market, By Form (2021 and 2028)
7.3 Capsules and Softgels
7.3.1 Overview
7.3.2 Capsules and Softgels: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.4 Gummies
7.4.1 Overview
7.4.2 Gummies: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.5 Liquid:
7.5.1 Overview
7.5.2 Liquid: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.6 Others
7.6.1 Overview
7.6.2 Others: North America Infant, Child, And Maternal Probiotic Supplements Market- Revenue and Forecast to 2028 (US$ Thousand)

8. North America Infant, Child, And Maternal Probiotic Supplements Market Analysis - By End User

8.1 Overview
8.2 North America Infant, Child, And Maternal Probiotic Supplements Market, By End User (2021 and 2028)
8.3 Infant and Toddler
8.3.1 Overview
8.3.2 Infant and Toddler: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
8.4 Children
8.4.1 Overview
8.4.2 Children: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
8.5 Maternal Women
8.5.1 Overview
8.5.2 Maternal Women: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)

9. North America Infant, Child, and Maternal Probiotic Supplements Market - Country Analysis

9.1 North America: North America Infant, Child, and Maternal Probiotic Supplements Market
9.1.1 North America: North America Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
9.1.2 North America: North America Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
9.1.2.1 US: North America Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9.1.2.1.1 US: North America Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.1.2.1.2 US: North America Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.1.2.2 Canada: North America Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9.1.2.2.1 Canada: North America Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.1.2.2.2 Canada: North America Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.1.2.3 Mexico: North America Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
9.1.2.3.1 Mexico: North America Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.1.2.3.2 Mexico: North America Infant, Child, and Maternal Probiotic Supplements Market, by End User

10. Industry Landscape

10.1 Overview
10.2 Product launch
10.3 Expansion

11. Company Profiles

11.1 Bayer Corporation
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 MaryRuth Organics, LLC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Mommy’s Bliss Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Pharmavite LLC
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Nestlé S.A.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 BioGaia AB
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Evolve Biosystems
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Lovebug Probiotics
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Biomeology
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Nordic Naturals
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments

12. Appendix

12.1 About the Publisher
12.2 Word Index

List of Tables

Table 1. North America Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
Table 2. North America Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 3. North America Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 4. US North America Infant, Child, and Maternal Probiotic Supplements Market, Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 5. US North America Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada North America Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Canada North America Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Mexico North America Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Mexico North America Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
Table 10. List of Abbreviation

List of Figures

Figure 1. North America Infant, Child, and Maternal Probiotic Supplements Market Segmentation
Figure 2. North America Infant, Child, and Maternal Probiotic Supplements Market Segmentation - By Country
Figure 3. North America Infant, Child, and Maternal Probiotic Supplements Market Overview
Figure 4. North America Infant, Child, and Maternal Probiotic Supplements Market: By Form
Figure 5. North America Infant, Child, and Maternal Probiotic Supplements Market: By Country
Figure 6. Porter's Five Forces Analysis: North America Infant, Child, and Maternal Probiotic Supplements Market
Figure 7. Expert Opinion
Figure 8. Ecosystem: North America Infant, Child, and Maternal Probiotic Supplements Market
Figure 9. North America Infant, Child, and Maternal Probiotic Supplements Market Impact Analysis of Drivers and Restraints
Figure 1. North America: North America Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 1. North America: North America Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, By Form (2021 and 2028)
Figure 1. Capsules and Softgels: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
Figure 1. Gummies: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
Figure 1. Liquid: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
Figure 1. Others: North America Infant, Child, And Maternal Probiotic Supplements Market- Revenue and Forecast To 2028 (US$ Thousand)
Figure 1. North America: North America Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
Figure 1. Infant and Toddler: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
Figure 1. Children: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
Figure 1. Maternal Women: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
Figure 20. North America: North America Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 21. North America: North America Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Country (2021 and 2028)
Figure 22. US: North America Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 23. Canada: North America Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 24. Mexico: North America Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)

Companies Mentioned

Bayer Corporation
MaryRuth Organics, LLC
Mommy’s Bliss Inc.
Pharmavite LLC
Nestlé S.A.
BioGaia AB
Evolve
Biosystems
Lovebug
Probiotics
Biomeology
Nordic Naturals

Table Information

Report Attribute	Details
No. of Pages	104
Published	October 2022
Forecast Period	2022 - 2028
Estimated Market Value ( USD ) in 2022	$ 237.56 Million
Forecasted Market Value ( USD ) by 2028	$ 386.82 Million
Compound Annual Growth Rate	8.5%
Regions Covered	North America
No. of Companies Mentioned	12

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2075EUR$2,100USD£1,727GBP €2964EUR$3,000USD£2,467GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€2767EUR$2,800USD£2,303GBP €3952EUR$4,000USD£3,290GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3458EUR$3,500USD£2,878GBP €4940EUR$5,000USD£4,112GBP

North America Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Form and End User

North America Infant, Child, and Maternal Probiotic Supplements Market Segmentation

North America Infant, Child, and Maternal Probiotic Supplements Market - Companies Mentioned

Table of Contents

Companies Mentioned

Table Information

North America Infant, Child, and Maternal Probiotic Supplements Market Segmentation

North America Infant, Child, and Maternal Probiotic Supplements Market - Companies Mentioned

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Child and Maternal Dietary Supplements Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031

Probiotics Dietary Supplements - Global Strategic Business Report

Postpartum Health Supplements Global Market Report 2024

Probiotic Dietary Supplement Market Report: Trends, Forecast and Competitive Analysis to 2030

Probiotic Dietary Supplements Market 2024-2028